Genetic Engineering and Human-Animal Hybrids: How China Is Leading a Global Split in Controversial Research
September 4, 2019
(The Conversation) – Yet if China is fast becoming the world capital of controversial science, it is not alone in producing it. More babies produced using the “CRISPR” gene-editing technology are now planned by a scientist in Russia, where another researcher is also hoping to conduct the world’s first human head transplant. And Japan has recently lifted its own ban on human-animal hybrids. The world is rapidly moving towards a two-tier system of cutting-edge medical research, broadly divided between countries with minimal regulation and those that refuse to allow anything but the earliest stages of this work. The consequences of this split are likely to be significant, even potentially affecting your own access to healthcare.